Yes Securities Ltd

Rollover Analysis – November 21 : Heavy weights ..

Heavy weights dragging on unabated FII’s selling Indian markets traded under pressure as FII’s continues to dump heavy, Nifty/BankNifty finished series wit..

Market Movements This Week By Mr. Amar Ambani, YE..

Below is quote on Market Movements This Week By Mr. Amar Ambani, Head – Institutional Equities, YES Securities “Structurally, our view ..

Reduce TTK Prestige Ltd For Target Rs.11,541 - Yes..

Solid all‐round performance with positives priced in; downgrade to REDUCE Our view TTKPT delivered a solid all‐round performance with highest ever quarterly rev..

Add Dr Lal Pathlabs Ltd For Target Rs.3,850 - Yes ..

Suburban acq. overshadows an inline Q Our view Acquisition of Suburban Diagnostics overshadowed what was an inline quarter with Covid revenues on the wane and expec..

Buy Greenpanel Industries Ltd : Continues to deliv..

Buy Greenpanel Industries Ltd For Target Rs.400 Continues to deliver strong growth! Our view Greenpanel Industries Ltd (GIL) reported robust growth in Q2FY22 bac..

Reduce Greenlam Industries Ltd For Target Rs.1,427..

Cost inflation dents margins! Our view Greenlam Industries Ltd (GRLM) reported massive topline growth of 57%YoY & 35%QoQ wherein laminates division (90% of biz)..

Add Johnson Controls‐Hitachi Air Conditioning In..

In‐line revenue but earnings disappoint due to margin fall; 2HFY22 needs to be closely monitored; maintain ADD Our view JCHAC delivered in‐line revenue growth b..

Add Gujarat Gas Ltd For Target Rs.650 - Yes Securi..

Margins weaken but demand sentiment strong Our view The 2QFY22 reported Ebitda stood at Rs 4.19bn, above our (YES: Rs 960mn) but below street estimates (Rs 5.4bn). ..

Buy Zydus Wellness Ltd For Target Rs.2,502 - Yes S..

Margin headwinds remain but consistent double-digit growth delivery keeps us positive; maintain BUY Our view While Q2 performance was disappointing on the margins f..

Add Dr Reddy's Laboratories Ltd For Target Rs. 5,3..

Focus on renewed US momentum Our view Dr Reddy’s inched up on the margin curve though aided by one offs in operating and proprietary income as well Covid drug..

Buy Ipca Laboratories Ltd For Target Rs.2,850 - Ye..

Temporary margin hiccup; rev drivers intact Our view IPCA domestic business continues to exhibit robust strength though exports formulations were largely affected w..

Buy Repco Home Finance Ltd For Target Rs.420 - Yes..

Delivered an operational beat; management change could be a trigger Our view Repco delivered a 10%/14%/23% beat on our NII/PPOP/PAT estimates, despite undershooting..